Your browser doesn't support javascript.
loading
Reperfusion therapies and poststroke seizures.
Bentes, Carla; Brigo, Francesco; Zelano, Johan; Ferro, José M.
Afiliação
  • Bentes C; Laboratory of EEG/Sleep, Neurophysiological Monitoring Unit, Department of Neuroscience and Mental Health (Neurology), Hospital de Santa Maria, CHULN, Lisbon, Portugal; Centro de Referência de Epilepsias Refratárias from EpiCare network (European Reference Network for rare and complex Epilepsies), H
  • Brigo F; Division of Neurology, "Franz Tappeiner" Hospital, Merano, Bolzano, Italy; Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Italy.
  • Zelano J; Sahlgrenska University Hospital and Sahlgrenska Academy, Gothenburg University, Sweden.
  • Ferro JM; Department of Neuroscience and Mental Health (Neurology), Hospital de Santa Maria, CHULN, Lisbon, Portugal; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Epilepsy Behav ; 104(Pt B): 106524, 2020 03.
Article em En | MEDLINE | ID: mdl-31727547
Seizures are not only a frequent complication of stroke but have been associated with an unfavorable functional and vital outcome of patients who have had stroke. Facing a new paradigm of acute standard stroke care, acute symptomatic seizures in this clinical setting deserve to be rethought. Reperfusion therapies, the gold standard treatment for acute ischemic stroke, improve long-term survival and outcome of patients who have had stroke and have been associated both with clinical seizures and the occurrence of epileptiform activity in the electroencephalogram (EEG). This narrative review describes the different physiopathological mechanisms underlying the possible association between reperfusion therapies and seizures, both acute symptomatic seizures and unprovoked seizures, and the current evidence regarding the risk of poststroke seizures in treated patients. It also identifies the gaps in our knowledge to foster future studies in this field. By different mechanisms, reperfusions therapies may have opposing effects on the risk of poststroke seizures. There is a need for a better definition of the specific physiopathology of seizures in clinical practice, as many factors can be recognized. Additionally, most of the current clinical evidence refers to acute symptomatic seizures and not to unprovoked seizures or poststroke epilepsy, and our analysis does not support the existence of a strong association between thrombolysis and poststroke seizures. So far, the impact of reperfusion therapies on the frequency of poststroke seizures is unclear. To study this effect, many clinical challenges must be overcome, including a better and clear operational definition of seizures and stroke characteristics, the standard of stroke and epilepsy care and EEG monitoring, and the degree of reperfusion success. Prospective, high quality, larger, and longer follow-up multicentric studies are urgently needed. Additionally, stroke registries can also prove useful in better elucidate whether there is an association between reperfusion therapies and seizures. This article is part of the Special Issue "Seizures & Stroke".
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Convulsões / Reperfusão / Isquemia Encefálica / Acidente Vascular Cerebral Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Convulsões / Reperfusão / Isquemia Encefálica / Acidente Vascular Cerebral Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article